MoneyWorks4Me

Amrutanjan Healthcar - Quaterly Results

04 Nov 2022 Evaluate
A minor change in the total revenue was seen in the September 2022 quarter. The total revenue for the quarter stood at Rs. 1107.19 millions against Rs. 1103.82 millions during year ago period.Net Profit of the company move down -35.69% to Rs. 127.64  millions from Rs. 198.47 millions  in the same quarter last year.Operating profit for the quarter ended September 2022 decreased to 189.61 millions as compared to 272.29 millions of corresponding quarter ended September 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 1107.19 1103.82 0.31 1816.73 1885.94 -3.67 4058.42 3328.44 21.93
Other Income 30.32 42.85 -29.24 60.44 70.24 -13.95 153.83 113.20 35.89
PBIDT 189.61 272.29 -30.36 253.03 445.20 -43.16 948.56 860.73 10.20
Interest 0.20 0.69 -71.01 0.44 1.54 -71.43 4.85 5.00 -3.00
PBDT 189.41 271.60 -30.26 252.59 443.66 -43.07 943.71 855.73 10.28
Depreciation 15.21 8.05 88.94 25.88 17.25 50.03 37.95 36.70 3.41
PBT 174.20 263.55 -33.90 226.71 426.41 -46.83 905.76 819.03 10.59
TAX 46.56 65.08 -28.46 62.43 107.37 -41.86 233.88 207.14 12.91
Deferred Tax 0.00 0.00 0.00 -1.74 0.00 0.00 0.00 0.00 0.00
PAT 127.64 198.47 -35.69 164.28 319.04 -48.51 671.88 611.89 9.80
Equity 29.23 29.23 0.00 29.23 29.23 0.00 29.23 29.23 0.00
PBIDTM(%) 17.13 24.67 -30.58 13.93 23.61 -41.00 23.37 25.86 -9.62
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..